Shield Therapeutics
AIM:STX
£ 0,09
£0,00 (0,00%)
0,09 £
£0,00 (0,00%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

£-0,02
Earnings Per Share
£0,09
Revenue Per Share
46,40%
Gross Margin %
£0,10 B
Market Cap
£0,02 B
Long-Term Debt
Earnings Per Share
£-0,02
Revenue Per Share
£0,09
Gross Margin %
46,40%
Market Cap
£0,10 B
Long-Term Debt
£0,02 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2011
EPS Earnings Per Share £-0,02 £-0,04 £-0,11 £-0,09 £-0,02 £-0,08 £-0,02 £-0,15 £-0,09 £0,00
Earnings Earnings £-5,19M £-31,28M £-28,53M £-19,43M £-2,35M £-9,38M £-2,33M £-17,46M £-9,73M £0,00M
RPS Revenue Per Share £0,09 £0,01 £0,02 £0,01 £0,09 £0,01 £0,10 £0,01 £0,00 N/A
Revenue Revenue £24,23M £10,46M £4,47M £1,52M £10,39M £0,72M £11,88M £0,64M £0,30M £0,00M
OCF Operating Cash Flow £-5,09M £-29,67M £-18,11M £-16,74M £-1,40M £-4,07M £-0,18M £-16,15M £-10,26M £0,00M
FCF Free Cash Flow £-6,91M £-27,78M £-18,38M £-17,11M £-1,42M £-5,42M £0,00M £-19,32M £-12,90M £0,00M
OM Operating Margin -71,08% -239,44% 0,00% 0,00% -20,74% 0,00% -43,42% 0,00% 0,00% 0,00%
GM % Gross Margin % 46,40% 30,78% 44,70% 35,48% 86,96% 32,55% 97,38% 75,67% 67,11% 0,00%
FCFS Free Cash Flow Per Share £-0,01 £-0,06 £-0,11 £-0,10 £-0,01 £-0,05 £-0,03 £-0,17 £-0,13 £0,00
LT Debt Long-Term Debt £20,91M £19,84M £6,68M N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 259,39M 782,06M 259,39M 215,89M 117,62M 117,19M 116,43M 116,43M 108,14M 0M
×